Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / *W EXP 09/02/202
-
Total 13F shares
-
3,223,277
-
Share change
-
-167,214
-
Total reported value
-
$903,887
-
Price per share
-
$0.07
-
Number of holders
-
14
-
Value change
-
-$11,140
-
Number of buys
-
2
-
Number of sells
-
4
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - *W EXP 09/02/202 (RCKTW) as of Q3 2024
As of 30 Sep 2024,
ROCKET PHARMACEUTICALS, INC. - *W EXP 09/02/202 (RCKTW) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,223,277 shares.
The largest 10 holders included
Altium Capital Management LP, Walleye Capital LLC, Sio Capital Management, LLC, RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, Fort Baker Capital Management LP, SILVERARC CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Affinity Asset Advisors, LLC, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.